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Abstract 
Background: Single variant approaches have been successful in identifying DNA methylation 
quantitative trait loci (mQTL), although as with complex traits they lack statistical power to 
identify effects from rare genetic variants. We have undertaken extensive analyses to identify 
regions of low frequency and rare variants that are associated with DNA methylation levels.  
Methods: We used repeated measurements of DNA methylation from five different life stages 
in human blood, taken from the Avon Longitudinal Study of Parents and Children (ALSPAC) 
cohort. Variants were collapsed across CpG islands and their flanking regions to identify 
variants collectively associated with methylation, where no single variant was individually 
responsible for the observed signal. All analyses were undertaken using the sequence kernel 
association test. 
Results: For loci where no individual variant mQTL was observed based on a single variant 
analysis, we identified 95 unique regions where the combined effect of low frequency variants 
(MAF≤5%) provided strong evidence of association with methylation. For loci where there 
was previous evidence of an individual variant mQTL, a further 3 regions provided evidence 
of association between multiple low frequency variants and methylation levels. Effects were 
observed consistently across 5 different time points in the lifecourse and evidence of replication 
in the TwinsUK and Exeter cohorts was also identified. 
Conclusion: We have demonstrated the potential of this novel approach to mQTL analysis by 
analysing the combined effect of multiple low frequency or rare variants. Future studies should 
benefit from applying this approach as a complementary follow up to single variant analyses.  
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Introduction 
Genome wide association studies (GWAS) have had a profound influence on the number of 
complex disease associated common variants identified. Current endeavours have now shifted 
to elucidate the functional role of these variants and better understanding the underlying 
mechanisms by which they influence phenotypic variance. One approach to this has been to 
determine their impact on DNA methylation, an epigenetic regulation mechanism known to 
play a key role in many biological processes and disease susceptibility(1, 2). Recent studies 
have found success in identifying methylation quantitative trait loci (mQTLs) using individual 
variant approaches(3-5). However, these approaches have limited power to detect effects from 
rare variants, which is also true when analysing complex phenotypic traits. However, there may 
be many low frequency and rare variants across the genome which may help explain a large 
proportion of the additive genetic variance of complex traits and diseases(6, 7). 
Collaborative efforts have found success in improving statistical power to detect disease 
associated rare variants by pooling large samples sizes together (termed meta-GWAS)(8, 9). 
However, adopting such an approach to uncover mQTL caused by rare variation is challenging 
for several reasons, such as measurements being taken from differing tissues types, samples 
with a wide range of disease states and matching studies which have defined different quality 
control parameters. An alternative and feasible approach to leverage statistical power for rare 
variants analysis involves collapsing them together across the same functional unit or genomic 
region and analysing their combined effect on phenotypic traits(10, 11).  
We have undertaken extensive analyses using repeated measures of methylation data from the 
Accessible Resource for Integrated Epigenomic Studies (ARIES)(12) project to identify mQTL 
effects from collapsed regions of low frequency and rare variants. Our sample consisted of 
mother-offspring pairs from the Avon Longitudinal Study of Parents and Children 
(ALSPAC)(13, 14) cohort. Our aim was to identify regions surrounding CpG islands where no 
single variant was sufficiently responsible for the observed association signal, but rather a 
combined effect contributed to by several variants not detected by a single variant analysis. 
Moreover, for CpG islands where there was evidence of a single variant mQTL, we wanted to 
investigate these regions to evaluate whether there were any independent effects from low 
frequency and rare variants.
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Results 
All analyses were undertaken using the ARIES dataset (12) which includes 450k DNA 
methylation data collected at five different time points across the life course using individuals 
from the ALSPAC cohort(13, 14). Study characteristics for data from ARIES can be located in 
Table 1. The childhood time point in ARIES (n=834, Mean Age = 7.49 (Standard Deviation = 
0.15), proportion female = 0.50) was selected as the discovery analysis for this study and all 
results are from this data unless stated otherwise. The imputed genotype dataset for these 
analyses contained 3,721,682 low frequency variants (MAF≤5%). 1,787,681 of these were rare 
variants (MAF ≤ 1%).  
 
Discovering Novel mQTL 
There were 27,176 CpG island regions according to UCSC annotations using the hg19 build 
of the human reference genome(15). 10,836 of these regions had a reported mQTL in close 
proximity (i.e. within the island or its flanking regions ± 1kb). This was based on the results 
of a single variant analysis previously undertaken in the ARIES dataset by Gaunt et al(16). Of 
the remaining 16,340 CpG islands, variants were first of all collapsed across just CpG islands 
themselves, followed by expanded regions of interest to also include flanking shore and shelf 
regions. The following numbers of regions had at least 2 low frequency or rare variants within 
them and were therefore eligible for analysis: 
1. 2,934 CpG islands with no flanking regions  
2. A further 8,701 CpG islands with shore regions (i.e. islands +2kbs up and downstream) 
3. A further 4,407 CpG islands with shore and shelf regions (i.e. islands +4kbs up and 
downstream). 
 
An illustration of these 3 definitions can be found in Figure 1.  
 
Cis-mQTLs: Each collapsed region of variants was analysed in turn with each good quality 
CpG probe (294,905 out of 485,577, based on evaluations by Naeem et al (17)) within 1 mega 
base (MB) distance of the region analysed to identify cis-effects. The Sequence Kernel 
association Test (SKAT)(18) was used in all analyses to evaluate associations between sets of 
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variants and methylation, using two MAF cut offs of ≤ 5% and ≤ 1%. For consistency, we 
applied the same p-value threshold as Gaunt et al. (19) when evaluating findings in the 
subsequent analyses (p < 1.0 x 10-14). 
Methylation levels at 5 positions were influenced by low frequency variants (MAF≤5%) that 
were restricted to being located within proximal CpG islands (Supplementary Table 1). 
Extending these regions to include variants within adjacent shores provided strong evidence 
of association for 90 unique regions, 88 of which were not identified when collapsing variants 
from island regions alone. The top hits for these results can be located in Table 2. Extending 
our region of interest out further to include islands along with shores and shelves identified 37 
unique regions with strong evidence of association for cis-mQTL, although only one of these 
regions was not previously identified using island and shore regions alone in the previous 
analyses (Supplementary Table 2). Q-Q plots for all these results can be found in Figure 2. 
Using a MAF threshold of ≤ 1%, we only observed strong evidence of association between 
one region of variants (chromosome 2: 233,243,999-233,248,448 (CpG island & shores)) and 
nearby CpG probe cg16700265, near ALPP (P=3.62 x 10-17). Results can be found in 
Supplementary Table 3-5.  
All sets of variants responsible for cis-mQTL effects that survived the correction for multiple 
comparisons were further evaluated by calculating individual variant effects using linear 
regression. This was to ensure that no single variant was independently responsible for 
evidence of association, as well as discerning which variants were collectively responsible for 
driving the observed signal (Supplementary Tables 6-11). 
 
Trans-mQTLs: 2,553,242,326 analyses were undertaken to evaluate all possible trans-mQTL 
using CpG islands and flanking shore regions ((8,701 regions x 294,905 probes) subtracting 
12,726,079 possible cis-mQTL effects). Due to the computational burden of this analysis, only 
CpG island and shore regions were evaluated as this region of interest appeared to be the most 
effective at identifying evidence of cis-mQTL in the previous analysis (88 of the 94 cis-mQTL 
effects were observed using this region of interest). 
Only one result survived the conservative multiple testing correction. The observed association 
was found between 9 low frequency variants (MAF ≤ 5%) located on chromosome 21 (between 
33982367-33987450, near C21orf5) and cg09050820 (chromosome 6:167586206 near 
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TCP10L2) with a p-value of 1.50 x 10-15. No observed associations survived the multiple 
testing correction using a cutoff of 1% MAF. Results can be found in Supplementary Tables 
12 and 13. 
 
Analyses in other time points 
All results that survived the correction for multiple testing were further evaluated using all 4 
other time points in the ARIES project which included offspring previously analysed as well 
as their mothers. Using the top 10 hits of the CpG island and shore analysis, which provided 
the strongest evidence of association for novel mQTL, we observed consistently low p-values 
across all other time points in ARIES. These results can be located in Table 3. Effects across 
other time points for all other hits can be located in Supplementary Tables 14 & 15. 
 
Replication in independent cohorts 
Evidence of replication for the top 10 hits in the CpG island and shores analysis was evaluated 
using individuals from two independent cohorts, TwinsUK (n=847) (20) and Exeter (n=608) 
(Hannon et al., manuscript in preparation). Replication analyses were successful as low p-
values were observed for each mQTL (P<0.01). Results can be found in Table 4. 
 
Leave-One-Out Analysis 
To ensure that our results were robust to outliers (i.e. individual low frequency/rare variants 
associated with extremely high/low methylation), we firstly generated box and whisker plots 
to visually inspect possible outliers for the top 10 hits of the CpG island and shore analysis 
(Supplementary Figure 1). These figures did not suggest outliers were an issue in our analysis, 
although to be certain we have also undertaken leave one out analyses to discern whether 
signals were driven by a single variant influenced by extreme measurements of methylation. 
Variants within regions were firstly pruned using plink software (21), followed by re-running 
our analysis for each mQTL except systematically removing individual variants in turn. Results 
were plotted with –log10 p-values on the y-axis and the variant removed on the x-axis. Overall, 
these results help illustrate that collapsed mQTL are a combined effect of low frequency and 
rare variants on DNA methylation, where evidence of association remains consistently strong 
even when removing each variant in turn. Furthermore, these results show that our approach is 
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robust to the presence of outliers and linkage disequilibrium between variants. The plots for 
these analyses can be located in Supplementary Figure 2. 
 
Whole Genome Sequence evaluation 
To verify that observed associations were not due to an overlapping rare variant in the probe 
sequence we identified a subset of 394 individuals from the discovery analysis who had whole 
genome sequence (WGS) data as part of the UK10K project(22). For the top 10 hits found in 
Table 2 from our discovery analysis, only 1 probe had an overlapping rare variant based on the 
UK10K WGS data (cg17132079). We therefore repeated the analysis of the 3 low frequency 
variants at the CpG island near MXRA8 and this probe. The observed p-value had attenuated 
due to the reduction in sample size (P=1.62x10-11). However, conditioning our analysis by 
including the overlapping rare variant as a covariate in our model we did not observe an 
attenuation in the observe effect (P=1.38x10-11), suggesting that this analysis was not biased 
by the overlapping rare variant. 
 
Conditional mQTL analysis 
For the remaining 10,836 CpG island regions not evaluated in the previous analysis, 2,433 had 
2 or more variants within their island or flanking shore region. These regions were not 
previously analysed due to evidence of mQTL detected in close proximity (±5kbs on the island) 
in the single variant analysis conducted by Gaunt et al(16). Therefore, these regions were 
analysed as before using SKAT but conditioning on the single variant responsible for the 
evidence of an mQTL detected at that loci. Variants which were in high linkage disequilibrium 
(LD) with the mQTL (defined as D’ ≥ 0.8) were removed for these regions also before.  
Results from this analysis suggested that methylation levels were influenced independently at 
3 loci by low frequency variants (MAF≤5%) after conditioning analyses on reported single 
mQTL effects. The nearest genes to these loci were PPP2R2A, C2orf80 and SLC32A1. All of 
these collapsed mQTL were acting in cis. The results for this analysis can be found in Table 5. 
Supplementary Table 16 includes all time points in ARIES where these effects were observed 
to have a p-value < 1 x 10-14. 
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Discussion 
We have undertaken a novel approach to mQTL analysis by investigating the combined impact 
of multiple low frequency and rare variants on DNA methylation. Altogether we identified 95 
unique regions of low frequency variants (MAF≤5%) that were collectively associated with 
DNA methylation. 94 of these were acting in cis (associated with methylation within 1MB 
distance away) and 1 in trans (greater than 1MB away). Importantly, none of these effects were 
driven by an individual variant and therefore were not identified in the single variant analysis. 
Evidence of replication was observed both internally and in external datasets for the top 10 hits 
of this analysis which supports evidence that these associations are driven by causal effects. 
We also identified a further 3 loci with previous evidence of an mQTL effect from the single 
variant analysis, where there was evidence of an independent signal from multiple low 
frequency variants. This approach was less successful in identifying association signals from 
regions of rare variation (MAF≤1%), although future studies with larger samples sizes may 
yield stronger evidence of association for these types of effects. 
We found that 88 of the 94 unique regions responsible for observed cis-mQTL effects were 
identified by expanding our region of interest from CpG islands to include flanking shore 
regions. When conducting a variant collapsing analysis, the definition of a functional unit or 
genomic region by which variants are collapsed together is crucial to identifying association 
signals (23). This is reflected in our study, as using CpG islands alone would have overlooked 
the vast majority of signals identified, whereas extending regions to include both shores and 
shelves also resulted in fewer association signals rather than just islands and shores alone. This 
is most likely due to an increased number of neutral variants in the analysis window, which 
incorporate statistical noise into the analysis (24). 
The strongest evidence of association in our study was a cis-mQTL identified near the PFKL 
gene region (P=6.24x10-24 in the discovery analysis). Methylation of the ATF-motif in PFKL 
was observed to be reduced in obese patients compared to non-obese controls in a study 
investigating epigenetic modifications in terms of the aetiology of type 2 diabetes (25). 
CLDN15 (P=1.26x10-20 in the discovery analysis) was another locus which provided evidence 
of association in this analysis. This gene was observed to be dysregulated according to 
methylation status in tumor cell lines according to a recent study (26). Amongst the other top 
hits in our discovery analysis were mQTL identified near the ZNF623 and PLA2G1B genes 
which have previously been reported to be hypermethylated (27, 28). Previous evidence 
9 
 
detected at these loci in methylation studies, along with the replication of these effects in 
external cohorts, supports the validity of the approach used in this study to detect mQTL caused 
by low frequency and rare variants. This is important for future studies interested in mQTL as 
single variant approaches may not have sufficient power to detect these types of effects. 
Extending analyses to loci where there was previous evidence of an mQTL effect detected 
using single variant approaches identified 3 more associations between multiple low frequency 
variants and methylation levels. Analyses were conditioned on the previously identified 
mQTL, which means that this evidence suggests that these association signals are independent 
of each other. As with the previous analyses, applying this approach with a MAF cutoff of ≤ 
1% lacked statistical power to detect any strong evidence of association. A reason for this may 
be due to the relatively small sample sizes for the data analysed in this study (n=~800). The 
validity of these approaches should still be useful for future studies with larger sample sizes, 
in terms of detecting combined effects from rare variants on DNA methylation which would 
not be identified using single marker approaches. One result which was of interest involved 
rare variants contributing to a cis effect at the DVL1 loci (P=6.26x10-14), as it is a previously 
reported imprinted gene (29). Although evidence was not quite strong enough to survive the 
strict p-value threshold used in this study, this is encouraging for future studies which hope to 
detect novel variants associated with methylation by applying this approach. 
Moreover, the analysis pipeline undertaken in this study can be adapted depending on the study 
hypothesis. For example, in this study we have collapsed low frequency and rare variants 
together based on CpG island regions, although collapsing variants together across gene 
regions may also be a viable approach to mQTL analysis. The genotype data used in this study 
was imputed SNP microarray data, which is suboptimal for identifying signals from rare 
genetic variants as on average there were 5.4 variants with a MAF less than or equal to 1% in 
CpG islands and flanking regions after applying appropriate quality filters. Therefore, applying 
this approach to next generation sequencing data which directly assays rare variants should 
identify evidence of association from rare genetic variants not detected in our study. 
Despite undertaking an exhaustive number of tests, we found identifying strong evidence of 
association for trans-mQTL challenging, an outcome also encountered by previous studies (3, 
30). This is likely due to smaller effect sizes relative to cis-mQTL, which is a trend also 
observed for trans-eQTL(31). Single variant approaches have been used to investigate the 
relationship between sequence variation, gene expression and DNA methylation(32). 
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Extending the analysis framework demonstrated in this study to also incorporate the combined 
impact of variants on gene expression is necessary to better understand the functional 
consequence of rare variants. Moreover, investigating the impact of environmental exposures 
known to influence DNA methylation would be worthwhile to establish whether these 
influenced the observed associations between low frequency variants and DNA methylation. 
The framework easily allows for this by adjusting for covariates in the model and the findings 
could be important in terms of the molecular mechanisms of complex disease. 
There are features of the ARIES project which should be taken into consideration when 
interpreting the results of this study. Firstly, all adults in the ARIES project are female and so 
sex was not a source of variability for the two respective time points. All methylation 
measurements are taken from peripheral blood, meaning we are unable to evaluate our findings 
using different tissue types. Furthermore, cord blood obtained from the birth time point is not 
equivalent to peripheral blood in its cell type composition. However, it has been reported that 
evidence for the majority of mQTL is consistent across tissue types (33) and the results in this 
study appear to reflect this as results were consistent across all time points in ARIES. 
The motivation for undertaking an analysis of the association of low frequency and rare 
variants with DNA methylation is driven by a desire to understand the contribution made by 
genotype to epigenetic variation and, in turn, the role that this might play in development and 
disease. The biological function of the loci identified as being associated with methylation 
variation in this study have not been explored here but future studies are warranted.  
In conclusion, we have presented a complementary approach to single variant mQTL analysis. 
Future studies should benefit from applying this approach as a follow-up analysis to uncover 
low frequency and rare variants associated with DNA methylation that may have been 
overlooked using single variant approaches.   
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Methods 
Accessible Resource for Integrative Epigenomic Studies project (ARIES)  
Study Sample: All samples in the discovery analysis are taken from the Avon Longitudinal 
Study of Parents and Children (ALSPAC)(13, 14). Blood samples were taken from 1018 
mother-offspring pairs (offspring at three timepoints and their mothers at two timepoints) who 
were enrolled as part of the Accessible Resource for Integrative Epigenomic Studies project 
(ARIES, http://www.ariesepigenomics.org.uk/)(12). For the purposes of the planned analyses, 
one timepoint in the offspring (Mean Age = 7.49 (Standard Deviation = 0.15), proportion 
female = 0.50), was designated for the discovery analysis, whereas measures from other 
timepoints were used to evaluate findings. As this data was analysed in a cross-sectional 
manner, adjustment for relatedness was not undertaken. Cord and peripheral blood samples 
were collected according to standard procedures for all available samples mother-offspring 
pairs at each time point. Written informed consent was obtained for all study participants. 
Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and 
the Local Research Ethics Committees. Please note that the study website contains details of 
all the data that is available through a fully searchable data dictionary (http://www.bris.ac.uk/
alspac/researchers/data-access/data-dictionary/). 
 
Methylation assays: DNA samples were bisulfite treated using the Zymo EZ DNA 
MethylationTM kit (Zymo, Irvine, CA). The Illumina HumanMethylation450 BeadChip 
(HM450k) was used to measure methylation across the genome and the following arrays were 
scanned using Illumina iScan, along with an initial quality review using GenomeStudio. A 
purpose-built laboratory information management system (LIMS) was responsible for 
generating batch variables during data generation. LIMS also reported quality control (QC) 
metrics for the standard probes on the HM450k for all samples and excluded those which failed 
QC. Data points with a read count of 0 or with low signal:noise ratio (based on a p-value > 
0.01) were also excluded. Methylation measurements were then compared across timepoints 
for the same individual and with SNP-chip data (HM450k probes clustered using k-means) to 
identify and remove sample mismatches. All remaining data from probes was normalised with 
the Touleimat and Tost(34) algorithms using R with the wateRmelon package(35). This was 
followed by rank-normalising the data to remove outliers. Potential batch effect were removed 
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by regressing data points on all covariates. These included the bisulfite-converted DNA (BCD) 
plate batch and white blood cell count which was adjusted for using the estimateCellCounts 
function in the minfi Bioconductor package(36). 
 
Genotyping assays: Genotype data were available for all ALSPAC individuals enrolled in the 
ARIES project, which had previously undergone quality control, cleaning and imputation at 
the cohort level. ALSPAC offspring selected for this project had previously been genotyped 
using the Illumina HumanHap550 quad genome-wide SNP genotyping platform (Illumina Inc, 
San Diego, USA) by the Wellcome Trust Sanger Institute (WTSI, Cambridge, UK) and the 
Laboratory Corporation of America (LCA, Burlington, NC, USA). Samples were excluded 
based on incorrect sex assignment; abnormal heterozygosity (<0.320 or >0.345 for WTSI data; 
<0.310 or >0.330 for LCA data); high missingness (>3%); cryptic relatedness (>10% identity 
by descent) and non-European ancestry (detected by multidimensional scaling analysis). After 
QC, 500,527 SNP loci were available for the directly genotype dataset. Data for ALSPAC 
mothers was generated using the Illumina human660W-quad genome-wide SNP genotyping 
platform (Illumina Inc, San Diego, USA) at the Centre National de Génotypage (CNG, Paris, 
France). Samples were excluded due to non-European ancestry, missingness, relatedness, 
heterozygosity or gender mismatches. PLINK (v1.07)(21) was used for QC on an initial set of 
10,015 subjects and 557,124 directly genotyped loci. Following QC the final directly 
genotyped dataset contained 526,688 SNP loci. 
Imputation was performed for all genotyped mothers and children to improve SNP density. 
ShapeIt (version 2 revision 727) was used to phase genotypes and Impute (version 2.2.2) was 
used to impute this data using the 1000 genomes reference panel (phase 1 version 3, phased 
using ShapeIt version 2, December 2013, using all populations). Genotypes were then filtered 
to include those with a Hardy-Weinberg equilibrium of P > 5×10-7, MAF ≤ 5% and imputation 
info score > 0.8. The final imputed dataset for all subsequent analyses contained 3,721,682 
loci. 1,787,681 of these had a MAF ≤ 1%. 
 
Replication Cohorts 
TwinsUK 
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The TwinsUK cohort was established in 1992 to recruit monozygotic and dizygotic twins(20). 
More than 80 % of participants are healthy female Caucasians (age range from 16 to 98 years 
old). The cohort includes more than 13,000 twin participants from all regions across the United 
Kingdom, and many have had multiple visits over the years. The TwinsUK cohort has been 
used in many epidemiological studies and is representative of the general UK population for a 
wide range of diseases and traits(37).  
Samples from TwinsUK were genotyped using the Illumina Hap317K and Hap610K assays 
(Illumina, San Diego, USA) following standard procedures. Normalised intensity data were 
pooled and genotypes called on the basis of the Illluminus algorithm(38). No calls were 
assigned if the most likely call was less than a posterior probability of 0.95. SNPs that had a 
low call rate (<95%), Hardy-Weinberg p values < 10−4 were excluded. We also removed 
subjects if the sample call rate was less than 95%, autosomal heterozygosity was outside the 
expected range, genotype concordance was over 97% with another sample and the sample was 
of lesser call rate. Imputation of genotypes was carried out using the software IMPUTE(39). 
DNA methylation was measured for 877 individuals randomly selected from the TwinsUK 
cohort, 847 who also had genetic information. The Infinium HumanMethylation450 BeadChip 
(Illumina Inc, San Diego, CA, USA) was used to measure DNA methylation. Details of 
experimental approaches have been previously described(40). Normalization was carried out 
using the “minfi” R package(41), a procedure equivalent to the Lumi:QN+BMIQ 
pipeline. DNA methylation probes that mapped incorrectly or to multiple locations in the 
reference sequence and probes with detection p value of >0.05 or missing values were 
removed, resulting in 452,874 probes. Blood cell type coefficients were estimated from the 
methylation data using the method described by Houseman et al.(42).  For this project, 
normalized methylation beta values were regressed out effects of family structure, batch effects 
and predicted cell counts data. The obtained methylation residuals were used to test the 
association between genetic variants and methylation.  
Exeter 
These samples are the first phase of a multi-stage case-control EWAS of schizophrenia 
(Hannon et al. 2016. Submitted). 500ng of DNA from each sample was treated with sodium 
bisulfite using the EZ-96 DNA Methylation kit (Zymo Research, CA, USA). DNA methylation 
was quantified using the Illumina Infinium HumanMethylation450 BeadChip (Illumina Inc, 
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CA, USA) run on an Illumina iScan System (Illumina, CA, USA) following a standard 
protocol. Samples were randomly assigned to chips and plates to ensure equal distribution of 
cases and controls across arrays and minimise batch effects.  Data were imported in R 
programming environment using the methylumIDAT() function in the methylumi package (43). 
Our stringent quality control pipeline included checking methylated and unmethylated signal 
intensities, bisulfite conversion efficacy, tissue prediction (of blood origin) from the Epigenetic 
Clock software (https://dnamage.genetics.ucla.edu/) (44), gender and detection p values of all 
samples.  Principal component (PC) analysis was used (calculated across all probes) to identify 
outliers, excluding samples > 2 standard deviations from the mean for both PC1 and PC2. 
Normalization of the DNA methylation data was performed used the dasen() function in the 
wateRmelon package (35). Genotyping was performed using the Affymetrix Mapping 500K 
Array and the Genomewide Human SNP Array 5.0 or 6.0 (Affymetrix, CA, USA). Genotypes 
were called from raw intensity data using the Birdseed component of the Birdsuite algorithm 
(45, 46).  Samples were genotyped by the Genetic Analysis Platform at The Broad Institute of 
Harvard and MIT according to standard protocols. All samples were concordant across the 
methylation and genotype data for SNPs assayed on both platforms. Prior to imputation, 
PLINK (21) was used to remove samples with >5% missing data. We also excluded SNPs 
characterized by >5% missing values, a Hardy-Weinberg equilibrium P-value < 0.001 and a 
minor allele frequency of <5%.  Imputation was performed using ChunkChromosome (http://
genome.sph.umich.edu/wiki/ChunkChromosome) and Minimac2 (47, 48) with the 1000 
Genomes reference panel of European samples (phase 1, version 3). Imputed genotypes were 
then converted back in the PLINK format files using GCTA software (49)  only including 
variants with Rsq > 0.1.  
 
The UK10K project 
DNA Samples from 4,030 UK10K study participants (2,040 offspring from the ALSPAC 
cohort, 1,990 from the TwinsUK cohort) were subjected to low coverage (6-8x average read 
depth) whole-genome sequencing (WGS). Sequencing was performed at both the Wellcome 
Trust Sanger Institute (WTSI) and the Beijing Genomics Institute (BGI). DNA (1-3μg) was 
sheared to 100–1000 bp using a Covaris E210 or LE220 (Covaris, Woburn, MA, USA). 
Sheared DNA was size subjected to Illumina paired-end DNA library preparation. Following 
size selection (300-500 bp insert size), DNA libraries were sequenced using the Illumina HiSeq 
platform as paired-end 100 base reads according to manufacturer’s protocol.  
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Data that passed quality control (QC) was aligned to the GRCh37 human reference used in 
phase 1 of the 1000 Genomes Project. Reads were aligned using BWA (v0.5.9-r16)(50). Of the 
4,030 participants, 3,910 samples (1,976 ALSPAC and 1,934 TwinsUK) went through the 
variant calling procedure. Low quality samples were identified by comparing the samples to 
their GWAS genotypes using about 20,000 sites on chromosome 20. A total of 112 samples 
(48 ALSPAC and 64 TwinsUK) were removed, leaving 3,798 samples (1,928 ALSPAC and 
1,870 TwinsUK) that were eligible for the genotype refinement phase.  
 
Missing and low-confidence genotypes in the filtered VCFs were refined out using the 
imputation procedure in BEAGLE 4(51) with default parameters. Additional sample-level QC 
steps were carried out on refined genotypes, resulting in 17 samples (16 TwinsUK and 1 
ALSPAC) being removed due to either non-reference discordance with GWAS SNV data>5%, 
multiple relations to other samples or failed sex check. A principal components analysis was 
conducted using EIGENSTRAT(52) to exclude participants of non-European ancestry after 
merging our data with a pruned 11 HapMap3 population dataset(53). 44 subjects (12 TwinsUK 
and 32 ALSPAC) did not cluster to the European (CEU) cluster and were removed. The final 
sample size for association analyses comprised of 3,621 individuals (1,754 TwinsUK and 1,867 
ALSPAC). 
 
Statistical Analysis 
Discovering Novel mQTL: Annotations for UCSC CpG Islands were obtained using the R 
Package ‘COHCAPanno’(15) according to the hg19 build of the human reference genome. All 
low frequency variants (MAF ≤ 5%) were collapsed together within regions where there were 
no mQTL loci identified from the individual variant analysis carried out by Gaunt et al(16) 
using the same dataset. These regions were defined as: 
1) CpG islands as defined by UCSC co-ordinates  
2) CpG islands and shores (i.e. islands +2kbs up and downstream)  
3) CpG islands, shores and shelves (i.e. islands +4kbs up and downstream).  
Cis-mQTL: Regions which had a reported mQTL in close proximity (CpG island ± 5kb) were 
not analysed here, but in a subsequent analyses conditioning on the reported mQTL effect. The 
remaining regions which had least 2 variants were analysed using the Sequence Kernel 
Association Test (SKAT)(18) with each CpG probe in turn that was within +/- 1Mb distance 
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from the region analysed(30)). Regions with only 1 variant were not evaluated as there was no 
benefit to applying a collapsing method in these instances. Other types of collapsing methods 
make assumptions about the direction of effect for variants within the analysis window. As we 
hypothesised that variants collapsed across these regions may have conflicting directions of 
effects (i.e. variants within a region may cause methylation levels to either increase or decrease 
at a particular loci), SKAT was chosen above alternatives. Details on SKAT can be found in 
the publication by Wu et al(18). In brief, SKAT uses a linear model in this study as our 
outcome of interest is continuous: 
yi = 0 + ’Xi + β’Gi + εi 
where y is the rank normalized measure of DNA methylation, 0 is the intercept term, 
[ 1,…, m]’is a vector of regression coefficients for m covariates, Xi = [Xi1,…,Xim] denotes 
covariates, β = [β1,…,βp]’ is the vector of regression coefficients for the p observed variants 
with a region,  Gi = [Gi1,…,Gip] denotes the genotypes for p variants within the region (i.e. 0, 
1 or 2) and ε is the error term. SKAT assumes that the genetic effect βj of an individual variants 
j follows an arbitrary distribution with mean 0 and variant wjτi where τ is a variance components 
and wj is a weight of variant j. SKAT assumes that √𝑤j follows a Beta(MAFj; a1, a2).  
This analysis was undertaken using two MAF cut offs of ≤ 5% (for low frequency variants) 
and ≤ 1% (for rare variants). We used a conservative multiple testing correction of P < 1.0x10-
14 as undertaken by Gaunt et al(16). This was to reduce the number of false positive findings, 
which was important in the absence of an appropriate replication sample for the planned 
analyses. Individual variant effects from regions that survived this correction were evaluated 
using linear regression to ensure that no individual variant would have been identified in the 
previous study, but when analysed together with other low frequency or rare variants we 
observed much stronger evidence that they were collectively influencing methylation.  
 
Trans-mQTL: We applied the same approach as above but to identify trans-mQTL (defined as 
associations between variants and CpG probes more than +/- 1Mb from regions analysed). Due 
to the computational demand required for the number of tests, we collapsed variants together 
only using CpG islands with flanking shore regions, as these regions provided the most number 
of association signals that survived the correction for multiple comparisons in the cis-analysis. 
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This analysis was undertaken using 2 MAF cutoffs of 5% and 1% and evaluated with the same 
multiple testing correction as before. 
 
Analyses in other time points: Analyses were initially undertaken using all available 
individuals from the Childhood time point in ARIES (Mean Age = 7.49 (Standard Deviation = 
0.15), proportion female = 0.50), which was designated as our discovery analysis. Results 
which survived the correction for multiple testing were further evaluated by analysing the same 
set of variants with methylation values measured at the same probe from all other time points 
in both children and mothers. These analyses were conducted using each time point in turn and 
without adjustment for relatedness. Variants which did not exist amongst the sample of mothers 
were not replaced in these analyses (i.e. we attempted to replicate effects with available variants 
without replacement). We did not evaluate all potential cis- and trans-mQTL at all time points 
due to the computationally exhaustive number of analyses needed, as well as the potential 
number of false positive findings incurred by doing so. Evidence that hits replicated at other 
time points was based on associations with a lower threshold p-value of p > 1 x 10-7 on the 
basis that these results are supported by their combination with other evidence from time points 
through the life course.   
 
Replication in independent cohorts: Replication analyses were conducted using SKAT to 
evaluate the association between sets of variants and DNA methylation using the same 450k 
probe ID. Variants which were not eligible or available within the replication cohorts were not 
included in replication analyses without replacement.  
 
Leave-One-Out Analysis: We firstly generated box and whisker plots for the top 10 hits of our 
analysis to discern whether extreme measures of DNA methylation were influencing our 
results. A leave one out analysis was also undertaken on the top 10 hits to further ensure that 
our results were not heavily influenced by potential outliers or individual effects. The purpose 
of this analysis was also to illustrate the combined effect of these sets of variants on 
methylation. Variants within regions were first of all pruned using plink software (21), 
followed by re-running our analysis for each mQTL except systematically removing individual 
variants in turn. Results were plotted with –log10 p-values on the y-axis and the variant 
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removed on the x-axis. Plots were annotated with red lines to show the observed p-value when 
all variants were analysed (prior to pruning). A blue line was also added to show the p-value 
threshold used in our study (i.e. p < 1.0 x 10-14).  
 
Whole Genome Sequence evaluation: To evaluate whether overlapping rare variants in the 
probe sequence was incorporating bias into our analysis we took a subset of individuals from 
the discovery analysis who had whole genome sequence (WGS) data from the UK10K project 
(22). This was due to the fact that Naeem et al had potentially not evaluated these variants in 
their study when looking at overlapping SNPs (17). Using the top 10 hits identified in our 
study, corresponding probe locations were identified to verify whether there was an 
overlapping variants in the WGS data. When this was the case, a conditional analysis was 
undertaken using individuals enrolled in both the ARIES project and UK10K. This analysis 
involved repeating the collapsed mQTL analysis as before except including the overlapping 
variant in the probe sequence as a covariate in the model. An attenuation in p-value would 
indicate that our analysis may be influenced by the overlapping rare variant in probe sequence. 
 
Conditional analysis for Regions with a single variant mQTL: For CpG island regions where 
an mQTL was identified in the previously undertaken single variant analysis, we undertook 
conditional analyses to evaluate whether there was an independent effect from regions of low 
frequency and rare variants at these loci. All CpG island regions not included in the previous 
analysis were eligible. mQTL results from the single variant analysis had been previously 
analysed with GCTA(49) to identify independent loci associated with each methylation probe.  
Low frequency variants (MAF≤5%) were collapsed as before within CpG islands and their 
flanking shore regions. Variants which were in high linkage disequilibrium (LD) with the 
mQTL (defined as D’ ≥ 0.8) were removed for these regions. r2 values for LD were not used 
as the range of r2 is dependent on allele frequencies, which could potentially be very different 
between a common SNP and rarer genetic variants. Regions with at least 2 variants remaining 
were analysed using SKAT with the corresponding probe which was associated with the single 
variant mQTL at this site. The SNP responsible for the mQTL was included as a covariate in 
the model. Analyses were run using 2 MAF cutoffs of 5% and 1% as before for the collapsed 
regions of low frequency variants. P-values lower than 1x10-14 were analysed a further time 
but including a covariate matrix consisting of all SNPs responsible for an mQTL effect at this 
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locus. This was to ensure results were not tagging a different mQTL signal not accounted for 
in the initial analysis. Analyses were undertaken using all time points in ARIES. All statistical 
analyses were undertaken using R statistical software(54). 
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Legends to Figures 
Figure 1: A Simple Diagram of a theoretical CpG Island and flanking regions. These 
regions of interest were proposed to aggregate variants together over and analyse their 
combined effect on measures of methylation at CpG probes. 
Figure 2: Quantile-Quantile plots for cis-mQTL analysis using three different regions of 
interest. Quantile-Quantile plots for results of the cis-mQTL analysis after aggregating 
variants according to 1) CpG islands 2) CpG islands & shores 3) CpG islands, shores and 
shelves. 
Tables 
Table 1: Study Characteristics  
Time point Sample Size Mean Age Proportion Female 
Birth 771 NA (all zero) 0.49 
Childhood 834 7.49 (0.15) 0.50 
Adolescence 837 17.14 (1.01) 0.49 
Pregnancy 764 29.22 (4.41) 1 (all female) 
Middle Age 742 47.45 (4.46) 1 (all female) 
- Study characteristics for ALSPAC individuals enrolled in the ARIES project across 5 
different life stages in human blood. 
 
Table 2: Analysis of Variants within CpG Islands & Shores (MAF ≤ 5%) 
CpG Island & Shores Nearest Gene Probe nVars P-value 
chr21:45728220..45732444 PFKL cg21069494 6 6.24x10-24 
chr8:144715866..144720798 ZNF623 cg16316162 3 4.02x10-23 
chr11:66492937..66498387 SPTBN2 cg24851651 6 2.68x10-21 
chr2:75785717..75790312 EVA1A cg26175789 8 6.73x10-21 
chr12:120753346..120757672 PLA2G1B cg06379361 5 1.21x10-20 
chr7:100873555..100878212 CLDN15 cg01299997 7 1.26x10-20 
chr3:53076956..53083101 RFT1 cg04865290 10 2.03x10-20 
chr2:196519555..196524950 SLC39A10 cg19655195 8 2.23x10-20 
chr1:1287707..1293126 MXRA8 cg17132079 3 1.11x10-19 
chr11:64407877..64413253 NRXN2 cg19395706 4 1.43x10-19 
Top 10 results for analysis between low frequency variants collapsed within CpG Island & flanking 
Shore regions (where there is no previously reported single variant mQTL effect) and nearby 
methylation probe (+/- 1Mb of region analysed). nVars = number of variants analysed. Probe = 450k 
probe ID. P-value = p-value according to SKAT. 
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Table 3: Evaluations using other time points in ARIES 
  
CpG Island & Shores 
 
Probe 
Offspring Mothers 
Birth   
(N=771) 
Adolescence 
(N=837) 
Pregnancy 
(N=764) 
Middle Age 
(N=742) 
chr21:45728220..45732444 cg21069494 9.34x10-20 1.63x10-18 2.15x10-18 2.39x10-20 
chr8:144715866..144720798 cg16316162 5.72x10-22 2.62x10-19 1.29x10-23 3.73x10-28 
chr11:66492937..66498387 cg24851651 1.06x10-12 7.04x10-17 4.52x10-12 1.76x10-11 
chr2:75785717..75790312 cg26175789 3.27x10-14 1.08x10-20 7.24x10-19 5.47x10-18 
chr12:120753346..120757672 cg06379361 3.99x10-20 8.86x10-16 3.66x10-19 6.11x10-21 
chr7:100873555..100878212 cg01299997 4.08x10-22 3.75x10-15 1.96x10-12 3.33x10-19 
chr3:53076956..53083101 cg04865290 1.34x10-12 6.69x10-24 3.82x10-22 1.99x10-13 
chr2:196519555..196524950 cg19655195 1.25x10-14 1.68x10-18 1.84x10-15 6.86x10-16 
chr1:1287707..1293126 cg17132079 2.99x10-13 4.02x10-20 1.06x10-14 4.54x10-14 
chr11:64407877..64413253 cg19395706 7.53x10-14 3.00x10-16 5.63x10-17 7.56x10-23 
Each column refers to a different time point within ARIES then the one used in the discovery analysis, as described in Table 1.All columns contain p-values 
according to SKAT. Probe = 450k probe ID, N = sample size at each time point. 
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Table 4: Replication analysis in the TwinsUK and Exeter Cohorts 
  
CpG Island & Shores 
 
Probe 
ALSPAC TwinsUK Exeter 
nVars P-value nVars P-value nVars P-value 
chr21:45728220..45732444 cg21069494 6 6.24x10-24 6 8.13x10
-5 0 N/A 
chr8:144715866..144720798 cg16316162 3 4.02x10-23 3 1.14x10
-6 2 4.67x10-18 
chr11:66492937..66498387 cg24851651 6 2.68x10-21 6 0.03 2 2.14x10
-4 
chr2:75785717..75790312 cg26175789 8 6.73x10-21 8 1.42x10
-3 5 7.57x10-16 
chr12:120753346..120757672 cg06379361 5 1.21x10-20 5 8.23x10
-3 2 1.63x10-7 
chr7:100873555..100878212 cg01299997 7 1.26x10-20 7 4.85x10
-5 3 8.45x10-3 
chr3:53076956..53083101 cg04865290 10 2.03x10-20 10 9.23x10
-6 3 5.44x10-18 
chr2:196519555..196524950 cg19655195 8 2.23x10-20 8 4.55x10
-3 3 1.85x10-7 
chr1:1287707..1293126 cg17132079 3 1.11x10-19 3 1.01x10
-3 0 N/A 
chr11:64407877..64413253 cg19395706 4 1.43x10-19 4 7.61x10
-7 0 N/A 
nVars = number of variants analysed. This varied depending on imputation quality for each cohort. P-value according to SKAT. 
 
 
 
 
 
 
 
 
26 
 
Table 5: Conditional Analysis of Low Frequency Variants Collapsed by CpG Island and Shore Regions with Single Variant mQTL 
nVars05 = number of variants analysed (MAF≤5%), P-value05 = SKAT p-value conditioned on single variant mQTL at this loci (MAF≤5%), nVars01 = 
number of variants analysed (MAF≤1%), P-value01 = SKAT p-value conditioned on single variant mQTL at this loci (MAF≤1%), SNP = mQTL variant at 
this loci associated with methylation from probe in single variant analysis, P-value = single variant p-value between SNP and probe from single variant 
analysis 
 
 
Conditional analysis results  Single Variant mQTL results 
Region Nearest Gene Probe nVars05 P-value05 nVars01 P-value01  SNP P-value 
chr2:208974900..208979396 C2orf80 cg10392614 5 2.56x10-20 0 NA  rs28575061 1.36x10-169 
chr20:37350130..37359372 SLC32A1 cg15490840 5 2.88x10-20 2 0.76  rs10932241 1.64x10-17 
chr8:26045804..26050097 PPP2R2A cg12285565 3 1.16x10-18 0 NA  rs2867326 1.00x10-19 
chr16:1003902..1008281 LMF1 cg07338658 5 3.34x10-13 0 NA  rs111820009 1.06x10-33 
chr19:41302467..41307050 RAB4B cg11298343 5 6.32x10-12 0 NA  rs111833532 9.61x10-50 
chr3:13321438..13326929 NUP210 cg05265484 3 8.54x10-12 0 NA  rs36024363 1.77x10-43 
chr2:1799618..1804060 MYT1L cg04722030 9 1.17x10-11 1 0.96  rs13387965 1.43x10-20 
chr13:111299316..111303593 CARS2 cg15747390 18 1.22x10-11 4 0.01  rs61970542 5.87x10-97 
chr3:112928437..112933506 BOC cg23260991 3 1.56x10-11 3 1.56 x10-11  rs931702 7.48x10-16 
chr1:91187139..91191400 BARHL2 cg22507154 4 1.42x10-10 3 9.14 x10-7  rs72720396 8.12x10-25 
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Abbreviations 
mQTL  - Methylation Quantitative Trait Loci 
ALSPAC – Avon Longitudinal Study of Parents and Children 
ARIES – Accessible Resource for Integrative Epigenomic Studies 
450k - Illumina HumanMethylation450 (450K) BeadChip array  
WGS – Whole Genome Sequence Data 
MAF – Minor Allele Frequency 
MB – Mega Base 
SKAT – Sequence Kernel Association Test  
LD – Linkage Disequilibrium 
Q-Q plot – Quantile-Quantile plot 
UCSC – University of California, Santa Cruz 
